Chatham Capital Group »

Amphastar Pharmaceuticals shares owned by Chatham Capital Group

Quarter-by-quarter ownership of Amphastar Pharmaceuticals (AMPH) shares owned by Chatham Capital Group from 13F filings

Historical chart of Chatham Capital Group investment in Amphastar Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals held by Chatham Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals by Chatham Capital Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 28k 48.53

More positions owned by Chatham Capital Group

Vanguard Index Fds Small Cp Etf (VB)
NVIDIA Corporation (NVDA)
Ishares Gold Tr Ishares New (IAU)
Apple (AAPL)
Vanguard Index Fds Large Cap Etf (VV)
Microsoft Corporation (MSFT)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard World Inf Tech Etf (VGT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Ibonds 27 Trm Ts (IBTH)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Invesco Exch Trd Slf Idx Bulshs 2027 Cb (BSCR)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)

View all positions for Chatham Capital Group

Top funds holding Amphastar Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
TD Asset Management
Federated Investors
Neuberger Berman Group
State Street Corporation
Hanna Zanoni
Epoch Investment Partners
Dimensional Fund Advisors
Geode Capital Management
American Century Companies
Morgan Stanley
Northern Trust
T. Rowe Price Associates

View all funds holding Amphastar Pharmaceuticals